# The Effect of Probiotic and Zinc Supplementation in Patients With Gastroesophageal Reflux Disease

> **NCT06664008** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Ain Shams University** · enrollment: 120 (estimated)

## Conditions studied

- Gastro-oesophageal Reflux Disease

## Interventions

- **DRUG:** PPI (proton pump inhibitor)
- **DRUG:** Probiotic
- **DRUG:** Zinc

## Key facts

- **NCT ID:** NCT06664008
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2025-03-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06664008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06664008, "The Effect of Probiotic and Zinc Supplementation in Patients With Gastroesophageal Reflux Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06664008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*